Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1809249 37 3. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112645982A details a scalable synthesis of Remdesivir intermediate INT using Lewis acid catalysis and perfluorinated solvent extraction for superior purity and yield.
Patent CN113214263B reveals a high-yield synthetic route for Remdesivir key intermediates, offering significant cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Novel patent CN113248538B details high-yield Remdesivir synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.